Encouraging results for Parkinson's Disease drug in Biovie study as more patients retain sufficient muscle control

Published on 16 June 2023

Encouraging clinical data has been released by Biovie, a company developing drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease.

Continue reading on website
Other news

Whitepaper: Informatica-Cognizant enabling data-driven transformation in life sciences

16 June 2023
Life sciences firms have always been at the forefront of technology adoption. The industry’s embrace of digital has been a catalyst for incredible change: accelerating innovation, getting products to market faster, growing market share, and improving efficiency.

Samsung Biologics speeds up $1.5 billion fifth plant, CEO reveals at BIO 2023

16 June 2023
Samsung Biologicsâ upcoming fifth plant will be operational by April 2025, five months earlier than previously expected, the biotech company revealed at BIO International Convention on Monday 5.